Artikel mit Open-Access-Mandaten - Jonathan J DennisWeitere Informationen
Nicht verfügbar: 2
In vitro lung delivery of bacteriophages KS4‐M and ΦKZ using dry powder inhalers for treatment of Burkholderia cepacia complex and Pseudomonas aeruginosa infections in cystic …
L Golshahi, KH Lynch, JJ Dennis, WH Finlay
Journal of applied microbiology 110 (1), 106-117, 2011
Mandate: Canadian Institutes of Health Research
Bacteriophage isolation, purification, and characterization techniques against ubiquitous opportunistic pathogens
DL Peters, G Harris, CM Davis, JJ Dennis, W Chen
Current Protocols 2 (11), e594, 2022
Mandate: Natural Sciences and Engineering Research Council of Canada
Verfügbar: 40
PHAST: a fast phage search tool
Y Zhou, Y Liang, KH Lynch, JJ Dennis, DS Wishart
Nucleic acids research 39 (suppl_2), W347-W352, 2011
Mandate: Canadian Institutes of Health Research, Genome Canada
Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections
S Matinkhoo, KH Lynch, JJ Dennis, WH Finlay, R Vehring
Journal of pharmaceutical sciences 100 (12), 5197-5205, 2011
Mandate: Canadian Institutes of Health Research
Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections
DD Semler, AD Goudie, WH Finlay, JJ Dennis
Antimicrobial agents and chemotherapy 58 (7), 4005-4013, 2014
Mandate: Canadian Institutes of Health Research
Experimental Bacteriophage Therapy Increases Survival of Galleria mellonella Larvae Infected with Clinically Relevant Strains of the Burkholderia cepacia Complex
KD Seed, JJ Dennis
Antimicrobial agents and chemotherapy 53 (5), 2205-2208, 2009
Mandate: Canadian Institutes of Health Research
Toward modern inhalational bacteriophage therapy: nebulization of bacteriophages of Burkholderia cepacia complex
L Golshahi, KD Seed, JJ Dennis, WH Finlay
Journal of aerosol medicine and pulmonary drug delivery 21 (4), 351-360, 2008
Mandate: Canadian Institutes of Health Research
A general protein O‐glycosylation system within the Burkholderia cepacia complex is involved in motility and virulence
KV Lithgow, NE Scott, JA Iwashkiw, ELS Thomson, LJ Foster, ...
Molecular microbiology 92 (1), 116-137, 2014
Mandate: National Health and Medical Research Council, Australia, Canadian Institutes …
Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex
KH Lynch, P Stothard, JJ Dennis
BMC genomics 11, 1-26, 2010
Mandate: Canadian Institutes of Health Research
The isolation and characterization of two Stenotrophomonas maltophilia bacteriophages capable of cross-taxonomic order infectivity
DL Peters, KH Lynch, P Stothard, JJ Dennis
BMC genomics 16, 1-15, 2015
Mandate: Natural Sciences and Engineering Research Council of Canada
Identification and Characterization of Type IV Pili as the Cellular Receptor of Broad Host Range Stenotrophomonas maltophilia Bacteriophages DLP1 and DLP2
JG McCutcheon, DL Peters, JJ Dennis
Viruses 10 (6), 338, 2018
Mandate: Natural Sciences and Engineering Research Council of Canada
A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence
ELS Thomson, JJ Dennis
Virulence 3 (3), 286-298, 2012
Mandate: Canadian Institutes of Health Research
Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages
KH Lynch, P Stothard, JJ Dennis
BMC genomics 13, 1-19, 2012
Mandate: Canadian Institutes of Health Research
The Promise of Bacteriophage Therapy for Burkholderia cepacia Complex Respiratory Infections
DD Semler, KH Lynch, JJ Dennis
Frontiers in cellular and infection microbiology 1, 27, 2012
Mandate: Canadian Institutes of Health Research
Advances in Phage Therapy: Targeting the Burkholderia cepacia Complex
P Lauman, JJ Dennis
Viruses 13 (7), 1331, 2021
Mandate: Natural Sciences and Engineering Research Council of Canada
The Potential of Phage Therapy against the Emerging Opportunistic Pathogen Stenotrophomonas maltophilia
JG McCutcheon, JJ Dennis
Viruses 13 (6), 1057, 2021
Mandate: Natural Sciences and Engineering Research Council of Canada
Inactivation of Burkholderia cepacia Complex Phage KS9 gp41 Identifies the Phage Repressor and Generates Lytic Virions
KH Lynch, KD Seed, P Stothard, JJ Dennis
Journal of virology 84 (3), 1276-1288, 2010
Mandate: Canadian Institutes of Health Research
Genomic sequence and activity of KS10, a transposable phage of the Burkholderia cepacia complex
AD Goudie, KH Lynch, KD Seed, P Stothard, S Shrivastava, DS Wishart, ...
BMC genomics 9, 1-14, 2008
Mandate: Canadian Institutes of Health Research
Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia
KH Lynch, AH Abdu, M Schobert, JJ Dennis
BMC genomics 14, 1-15, 2013
Mandate: Canadian Institutes of Health Research
Novel Stenotrophomonas maltophilia temperate phage DLP4 is capable of lysogenic conversion
DL Peters, JG McCutcheon, P Stothard, JJ Dennis
BMC genomics 20, 1-17, 2019
Mandate: Natural Sciences and Engineering Research Council of Canada
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt